Cargando…

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review

Awareness increases that the tumor biology influences treatment outcome and prognosis in cancer. Tumor hypoxia is thought to decrease sensitivity to radiotherapy and some forms of chemotherapy. Presence of hypoxia may be assessed by investigating expression of endogenous markers of hypoxia (EMH) usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swartz, Justin E, Pothen, Ajit J, Stegeman, Inge, Willems, Stefan M, Grolman, Wilko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529348/ https://www.ncbi.nlm.nih.gov/pubmed/25919147 http://dx.doi.org/10.1002/cam4.460

Ejemplares similares

HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation
por: van Kempen, Pauline M W, et al.
Publicado: (2014)

Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
por: Fan, Cui, et al.
Publicado: (2021)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas
por: Wong, Nathan, et al.
Publicado: (2016)

The prognostic role of C‐reactive protein in patients with head and neck squamous cell carcinoma: A meta‐analysis
por: Chen, Yanglan, et al.
Publicado: (2020)

Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma
por: van Kempen, Pauline M W, et al.
Publicado: (2015)

Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD‐L1
por: Zhang, Pei, et al.
Publicado: (2018)

Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR‐421 and E‐cadherin
por: Ji, Yefeng, et al.
Publicado: (2020)

Proliferative exhausted CD8(+) T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma
por: Cheng, Danni, et al.
Publicado: (2023)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors
por: van Kempen, Pauline M. W., et al.
Publicado: (2016)

Construction of a combined hypoxia and EMT index for head and neck squamous cell carcinoma
por: Li, Huan, et al.
Publicado: (2022)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Reporting Quality of Systematic Reviews and Meta-Analyses of Otorhinolaryngologic Articles Based on the PRISMA Statement
por: Peters, Jeroen P. M., et al.
Publicado: (2015)

Assessment of the Quality of Reporting of Randomised Controlled Trials in Otorhinolaryngologic Literature – Adherence to the CONSORT Statement
por: Peters, Jeroen P. M., et al.
Publicado: (2015)

The risk of bias in randomized controlled trials in otorhinolaryngology: hardly any improvement since 1950
por: Peters, Jeroen P. M., et al.
Publicado: (2017)

FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis
por: Huang, Junjie, et al.
Publicado: (2021)

Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
por: Rangabashyam, Mahalakshmi S., et al.
Publicado: (2020)

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma
por: Weed, Donald T., et al.
Publicado: (2023)

An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma
por: Oyelakin, Akinsola, et al.
Publicado: (2023)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
por: Wang, Lihua, et al.
Publicado: (2018)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018)

HOTAIRM1 competed endogenously with miR‐148a to regulate DLGAP1 in head and neck tumor cells
por: Zheng, Mei, et al.
Publicado: (2018)

Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development
por: Barber, Paul R, et al.
Publicado: (2022)

Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck
por: Kunder, Shreya, et al.
Publicado: (2021)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021)

Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies
por: Stein, Andrew P, et al.
Publicado: (2015)

Quality of reporting of otorhinolaryngology articles using animal models with the ARRIVE statement
por: Bezdjian, Aren, et al.
Publicado: (2017)

Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma
por: Yang, Cuifang, et al.
Publicado: (2022)

Prognostic implications of peritumoral vasculature in head and neck cancer
por: Evans, Michael, et al.
Publicado: (2018)

Evaluation of the Quality of Reporting of Observational Studies in Otorhinolaryngology - Based on the STROBE Statement
por: Hendriksma, Martine, et al.
Publicado: (2017)

Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck
por: Schell, Amy, et al.
Publicado: (2015)

Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma
por: Koole, Koos, et al.
Publicado: (2015)

Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy
por: Hanamoto, Atsushi, et al.
Publicado: (2014)

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
por: Wilson, Harper L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_li6ic04tm8d97setsl4hbq912e